Mengjie Ye

机构：China Pharmaceutical University, Nankai University

发表论文 9 篇 · 总被引 63 次 · h-index 5

代表论文

• Reduction-triggered polycyclodextrin supramolecular nanocage induces immunogenic cell death for improved chemotherapy (2022 · Carbohydrate Polymers · 被引 22)
• Ultrasound-Energized OX40L-Expressing Biohybrid for Multidimensional Mobilization of Sustained T Cell-Mediated Antitumor Immunity and Potent Sono-Immunotherapy (2025 · Journal of the American Chemical Society · 被引 20)
• A Keap1-recruiting BRD4 degrader offers a single-molecular polypharmacology approach for the treatment of metabolic dysfunction-associated steatohepatitis (2025 · Free Radical Biology and Medicine · 被引 8)
• Harnessing Targeted Photodynamic Therapy to Synergistically Activate T Cell and NK Cell Responses in Multiple Myeloma (2025 · Advanced Materials · 被引 6)
• A Spatiotemporally Controlled and Mitochondria-Targeted Prodrug of Hydrogen Sulfide Enables Mild Mitochondrial Uncoupling for the Prevention of Lipid Deposition (2024 · Journal of Medicinal Chemistry · 被引 5)
• Activatable ImmunotheranosticNanovesicles for CoordinatedPhagocytic Reprogramming and Real-Time Immune Monitoring (2026 · Journal of the American Chemical Society · 被引 1)